Background High CHA(2)DS(2)-VASc score (Congestive heart failure, Hypertension, Age > 75 years, Diabetes mellitus, prior Stroke or transient ischemic attack or thromboembolism, Vascular disease, Age 65-74 and Sex category) was associated with adverse clinical outcomes in different settings.The aim of the present study was to evaluate the association between CHA(2)DS(2)-VASc score and R(2)CHA(2)DS(2)-VASc score (which includes renal impairment) with in-hospital mortality and length of hospital stay in patients hospitalized in an internal medicine ward.Methods We enrolled 983 consecutive patients admitted during 3 years in an internal medicine ward. R(2)CHA(2)DS(2)-VASc score was calculated by adding 2 points to CHA(2)DS(2)-VASc for the presence of chronic kidney disease (CKD), defined according to K-DOQI. The primary outcome was a composite of all-cause mortality and length of hospital stay > 10 days.Results Patients with CKD stages 3-5 presented with increased CHA(2)DS(2)-VASc vs stages 1-2 (p < 0.001). The composite outcome occurred in 47.3% of inpatients. Multivariable linear logistic regression analyses adjusted for presence of infectious diseases and cancer, with the occurrence of composite outcome showed an adjusted OR of 1.349 (95% CI 1.248-1.462) and 1.254 (95% CI 1.179-1.336) for CHA(2)DS(2)-VASc and R(2)CHA(2)DS(2)-VASc scores, respectively. No differences were found in the association between CHA(2)DS(2)-VASc and R(2)CHA(2)DS(2)-VASc scores with the composite outcome (AUC 0.631 vs 0.630), and furthermore, adding the presence/absence of infectious diseases during hospitalization and positive cancer history to the models increased the AUC (0.667 and 0.663).Conclusions Incrementally higher CHA(2)DS(2)-VASc score is associated with increased length of hospital stay and mortality in patients hospitalized in an internal medicine ward, regardless of the presence of CKD.

CHA2DS2-VASc score as a predictor of clinical outcomes in hospitalized patients with and without chronic kidney disease / Gigante, Antonietta; Imbimbo, Giovanni; Andreini, Martina; Proietti, Marco; Palladino, Mariangela; Molfino, Alessio; Alunni Fegatelli, Danilo; Muscaritoli, Maurizio. - In: JN. JOURNAL OF NEPHROLOGY. - ISSN 1121-8428. - (2023). [10.1007/s40620-023-01805-7]

CHA2DS2-VASc score as a predictor of clinical outcomes in hospitalized patients with and without chronic kidney disease

Gigante, Antonietta;Imbimbo, Giovanni;Andreini, Martina;Molfino, Alessio;Alunni Fegatelli, Danilo;Muscaritoli, Maurizio
2023

Abstract

Background High CHA(2)DS(2)-VASc score (Congestive heart failure, Hypertension, Age > 75 years, Diabetes mellitus, prior Stroke or transient ischemic attack or thromboembolism, Vascular disease, Age 65-74 and Sex category) was associated with adverse clinical outcomes in different settings.The aim of the present study was to evaluate the association between CHA(2)DS(2)-VASc score and R(2)CHA(2)DS(2)-VASc score (which includes renal impairment) with in-hospital mortality and length of hospital stay in patients hospitalized in an internal medicine ward.Methods We enrolled 983 consecutive patients admitted during 3 years in an internal medicine ward. R(2)CHA(2)DS(2)-VASc score was calculated by adding 2 points to CHA(2)DS(2)-VASc for the presence of chronic kidney disease (CKD), defined according to K-DOQI. The primary outcome was a composite of all-cause mortality and length of hospital stay > 10 days.Results Patients with CKD stages 3-5 presented with increased CHA(2)DS(2)-VASc vs stages 1-2 (p < 0.001). The composite outcome occurred in 47.3% of inpatients. Multivariable linear logistic regression analyses adjusted for presence of infectious diseases and cancer, with the occurrence of composite outcome showed an adjusted OR of 1.349 (95% CI 1.248-1.462) and 1.254 (95% CI 1.179-1.336) for CHA(2)DS(2)-VASc and R(2)CHA(2)DS(2)-VASc scores, respectively. No differences were found in the association between CHA(2)DS(2)-VASc and R(2)CHA(2)DS(2)-VASc scores with the composite outcome (AUC 0.631 vs 0.630), and furthermore, adding the presence/absence of infectious diseases during hospitalization and positive cancer history to the models increased the AUC (0.667 and 0.663).Conclusions Incrementally higher CHA(2)DS(2)-VASc score is associated with increased length of hospital stay and mortality in patients hospitalized in an internal medicine ward, regardless of the presence of CKD.
2023
cha2ds2-vasc score; chronic kidney disease; internal medicine; mortality; length of stay
01 Pubblicazione su rivista::01a Articolo in rivista
CHA2DS2-VASc score as a predictor of clinical outcomes in hospitalized patients with and without chronic kidney disease / Gigante, Antonietta; Imbimbo, Giovanni; Andreini, Martina; Proietti, Marco; Palladino, Mariangela; Molfino, Alessio; Alunni Fegatelli, Danilo; Muscaritoli, Maurizio. - In: JN. JOURNAL OF NEPHROLOGY. - ISSN 1121-8428. - (2023). [10.1007/s40620-023-01805-7]
File allegati a questo prodotto
File Dimensione Formato  
Gigante_High-Cha2ds2‑vasc-score_2023.pdf

accesso aperto

Tipologia: Versione editoriale (versione pubblicata con il layout dell'editore)
Licenza: Creative commons
Dimensione 1.88 MB
Formato Adobe PDF
1.88 MB Adobe PDF

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11573/1700338
Citazioni
  • ???jsp.display-item.citation.pmc??? 0
  • Scopus 1
  • ???jsp.display-item.citation.isi??? 1
social impact